Please ensure Javascript is enabled for purposes of website accessibility

Why Ontrak Stock Plunged and Then Recovered Today

By Jeremy Bowman – Aug 20, 2021 at 2:12PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Analysts weighed in after the telehealth company lost its biggest customer.

What happened

Shares of Ontrak (OTRK -3.16%) tumbled this morning, continuing yesterday's slide after the company said it lost yet another large customer. Today, some analysts downgraded the telehealth stock in response to the news, but it recovered nearly all of those losses by the afternoon as some investors saw the sell-off as a buying opportunity, including an analyst from Benchmark.

As of 1:20 p.m. EDT on Friday, the stock was down 2.9% after trading as much as 18.6% lower earlier in the session. Yesterday, the stock plunged 45%.

An older man talking to a doctor on a computer.

Image source: Getty Images.

So what

In a filing yesterday, Ontrak said it was notified by a large customer, believed to be Cigna, that it would be ending its contract early due to what Ontrak believed to be a change in its corporate strategy. The contract was for three years and $90 million, and Ontrak had so far billed $42 million. Its most recent guidance called for $80 million to $85 million in 2021 revenue, so Cigna's portion represents more than a third of the total.

This morning, a number of analysts downgraded the stock. B. Riley lowered its price target on Ontrak from $58 to $15 and cut its rating from buy to neutral. Cowen also downgraded the telehealth stock to underperform from neutral, and Benchmark lowered its price target from $35 to $16, but maintained a buy rating, with analyst Bill Sutherland arguing that the company's value proposition remained intact.  

Now what

Ontrak has been unusually volatile during the pandemic, when the stock jumped to nearly $100 a share earlier this year as some investors imagined it as another Teladoc. The stock plunged soon after, when it was forced to slash its revenue guidance after it lost another major customer. It now trades for less than $12 a share.

In its filing, Ontrak said it continues to add new customers, and revenue from its remaining customer base should grow 62% next year. If the two customer losses prove to be isolated events, this could be a buying opportunity, but it's hard not to be cautious with the stock given that it's fallen by nearly 90% since February.

Jeremy Bowman owns shares of Teladoc Health. The Motley Fool owns shares of and recommends Teladoc Health. The Motley Fool has a disclosure policy.

Stocks Mentioned

Ontrak, Inc. Stock Quote
Ontrak, Inc.
$0.41 (-3.16%) $0.01
Teladoc Health Stock Quote
Teladoc Health
$27.08 (-7.26%) $-2.12
Cigna Stock Quote
$327.39 (0.40%) $1.31

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.